Glycogen synthase kinase-3β mediates convergence of protection signalling to inhibit the mitochondrial permeability transition pore

Journal of Clinical Investigation

Volumn 113, Issue 11, 2004, Pages 1535-1549

  Juhaszova, Magdalena ^a   Zorov, Dmitry B ^a,b   Kim, Suhn Hee ^a,c   Pepe, Salvatore ^a,d   Fu, Qin ^a   Fishbein, Kenneth W ^a   Ziman, Bruce D ^a   Wang, Su ^a   Ytrehus, Kirsti ^a,e   Antos, Christopher L ^f   Olson, Eric N ^f   Sollott, Steven J ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b MOSCOW STATE UNIVERSITY   (Russian Federation)

^c Chonbuk National University Medical School   (South Korea)

^d MONASH UNIVERSITY   (Australia)

^e UNIVERSITY OF TROMSØ   (Norway)

^f UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; G PROTEIN COUPLED RECEPTOR; GLYCOGEN SYNTHASE KINASE 3BETA; MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN; PROTEIN KINASE B; PROTEIN KINASE C; PROTEIN TYROSINE KINASE; REACTIVE OXYGEN METABOLITE; S6 KINASE; UNCLASSIFIED DRUG; CARRIER PROTEIN; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; ION CHANNEL; MITOCHONDRIAL PERMEABILITY TRANSITION PORE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPOLARIZATION; ENZYME INHIBITION; HEART MUSCLE CELL; HYPOXIA; MEMBRANE PERMEABILITY; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL PERMEABILITY; MITOCHONDRION; MITOCHONDRION SWELLING; NONHUMAN; OXIDATION; PRIORITY JOURNAL; RAT; REOXYGENATION; SIGNAL TRANSDUCTION; STRESS; ANIMAL; ANOXIA; DRUG ANTAGONISM; METABOLISM; PHYSIOLOGY; RESPIRATORY BURST; SPRAGUE DAWLEY RAT;

ANIMALS; ANOXIA; GLYCOGEN SYNTHASE KINASE 3; ION CHANNELS; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; MYOCYTES, CARDIAC; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; RESPIRATORY BURST; SIGNAL TRANSDUCTION;

EID: 85047692700     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI19906     Document Type: Article

References (62)

1. Green, D.R., and Reed, J.C. 1998. Mitochondria and apoptosis. Science. 281:1309-1312.
2. Murry, C.E., Jennings, R.B., and Reimer, K.A. 1986. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 74:1124-1136.
3. Kloner, R.A., Bolli, R., Marban, E., Reinlib, L., and Braunwald, E. 1998. Medical and cellular implications of stunning, hibernation, and preconditioning: an NHLBI workshop. Circulation. 97:1848-1867.
4. Inoue, I., Nagase, H., Kishi, K., and Higuti, T. 1991. ATP-sensitive K+ channel in the mitochondrial inner membrane. Nature. 352:244-247.
5. Garlid, K.D., et al. 1997. Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive K+ channels. Possible mechanism of cardioprotection. Cire. Res. 81:1072-1082.
6. Gross, G.J. 2000. The role of mitochondrial KATP channels in cardioprotection. Basic Res. Cardiol. 95:280-284.
7. Kloner, R.A., and Jennings, R.B. 2001. Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: part 2. Circulation. 104:3158-3167.
8. Schulz, R., Cohen, M.V., Behrends, M., Downey, J.M., and Heusch, G. 2001. Signal transduction of ischemic preconditioning. Cardiovasc. Res. 52:181-198.
9. Akao, M., Teshima, Y., and Marban, E. 2002. Antiapoptotic effect of nicorandil mediated by mitochondrial ATP-sensitive potassium channels in cultured cardiac myocytes. J. Am. Coll. Cardiol. 40:803-810.
10. Hunter, D.R., and Haworth, R.A. 1979. The Ca2+-induced membrane transition in mitochondria. I. The protective mechanisms. Arch. Biochem. Biophys. 195:453-459.
11. Crompton, M., and Costi, A. 1990. A heart mitochondrial Ca2+-dependent pore of possible relevance to re-perfusion-induced injury. Evidence that ADP facilitates pore interconversion between the closed and open states. Biochem. J. 266:33-39.
12. Halestrap, A.P., and Brenner, C. 2003. The adenine nucleotide translocase: a central component of the mitochondrial permeability transition pore and key player in cell death. Curr. Med. Chem. 10:1507-1525.
13. Javadov, S.A., et al. 2003. Ischaemic preconditioning inhibits opening of mitochondrial permeability transition pores in the reperfused rat heart. J. Physiol. 549:513-524.
14. Hausenloy, D.J., Maddock, H.L., Baxter, G.F., and Yellon, D.M. 2002. Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning? Cardiovasc. Res. 55:534-543.
15. Korge, P., Honda, H.M., and Weiss, J.N. 2002. Protection of cardiac mitochondria by diazoxide and protein kinase C: implications for ischemic preconditioning. Proc. Natl. Acad. Sci. U. S. A. 99:3312-3317.
16. Akao, M., et al. 2003. Differential actions of cardioprotective agents on the mitochondrial death pathway. Circ. Res. 92:195-202.
17. Zorov, D.B., Filburn, C.R., Klorz, L.O., Zweier, J.L., and Sollott, S.J. 2000. Reactive oxygen species (ROS)-induced ROS release: a new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes. J. Exp. Med. 192:1001-1014.
18. Tong, H., Imahashi, K., Steenbergen, C., and Murphy, E. 2002. Phosphorylation of glycogen synthase kinase-3beta during preconditioning through a phosphatidylinositol-3-kinase-dependent pathway is cardioprotective. Circ. Res. 90:377-379.
19. Woodgett, J.R. 1990. Molecular cloning and expression of glycogen synthase kinase-3/factor A. EMBO J. 9:2431-2438.
20. Plyte, S.E., Hughes, K., Nikolakaki, E., Pulverer, B.J., and Woodgett, J.R. 1992. Glycogen synthase kinase-3: functions in oncogenesis and development. Biochim. Biophys. Acta. 1114:147-162.
21. Hoeflich, K.P., et al. 2000. Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation. Nature. 406:86-90.
22. Cohen, P., and Frame, S. 2001. The renaissance of GSK3. Nat. Rev. Mol. Cell Biol. 2:769-776.
23. Cross, D.A., Alessi, D.R., Cohen, P., Andjelkovich, M., and Hemmings, B.A. 1995. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature. 378:785-789.
24. Antos, C.L., et al. 2002. Activated glycogen synthase-3 beta suppresses cardiac hypertrophy in vivo. Proc. Natl. Acad. Sci. U. S. A. 99:907-912.
25. Capogrossi, M.C., Kort, A.A., Spurgeon, H.A., and Lakatta, E.G. 1986. Single adult rabbit and rat cardiac myocytes retain the Ca2+- and species-dependent systolic and diastolic contractile properties of intact muscle. J. Gen. Physiol. 88:589-613.
26. Chesley, A., et al. 2000. The beta(2)-adrenetgic receptor delivers an antiapoptotic signal to cardiac myocytes through G(i)-dependent coupling to phosphatidylinositol 3′-kinase. Circ. Res. 87:1172-1179.
27. Vila Petroff, M.G., et al. 2001. Endogenous nitric oxide mechanisms mediate the stretch dependence of Ca2+ release in cardiomyocytes. Nat. Cell Biol. 3:867-873.
28. Mannella, C.A., and Parsons, D.P. 1977. Small-angle X-ray scattering from mitochondria. Biochim. Biophys. Acta. 470:242-250.
29. Aon, M.A., Cortassa, S., Marban, E., and O'Rourke, B. 2003. Synchronized whole cell oscillations in mitochondrial metabolism triggered by a local release of reactive oxygen species in cardiac myocytes. J. Biol. Chem. 278:44735-44744.
30. Chen, L., et al. 2001. Opposing cardioprotective actions and parallel hypertrophic effects of delta PKC and epsilon PKC. Proc. Natl. Acad. Sci. U. S. A. 98:11114-11119.
31. Pain, T., et al. 2000. Opening of mitochondrial K(ATP) channels triggers the preconditioned state by generating free radicals. Circ. Res. 87:460-466.
32. Chance, B., Sies, H., and Boveris, A. 1979. Hydroperoxide metabolism in mammalian organs. Physiol. Rev. 59:527-605.
33. Dos Santos, P., et al. 2002. Mechanisms by which opening the mitochondrial ATP-sensitive K+ channel protects the ischemic heart. Am. J. Physiol. 283: H284-H295.
34. Vila Petroff, M.G., Egan, J.M., Wang, X., and Sollott, S.J. 2001. Glucagon-like peptide-1 increases cAMP but fails to augment contraction in adult rat cardiac myocytes. Circ. Res. 89:445-452.
35. Kowaltowski, A.J., Castilho, R.F., and Vercesi, A.E. 2001. Mitochondrial permeability transition and oxidative stress. FEBS Lett. 495:12-15.
36. Halestrap, A.P. 1989. The regulation of the matrix volume of mammalian mitochondria in vivo and in vitro and its role in the control of mitochondrial metabolism. Biochim. Biophys. Acta. 973:355-382.
37. Atkinson, L.L., Fischer, M.A., and Lopaschuk, G.D. 2002. Leptin activates cardiac fatty acid oxidation independent of changes in the AMP-activated protein kinase-aceryl-CoA carboxylase-malonyl-CoA axis. J. Biol. Chem. 277:29424-29430.
38. Minokoshi, Y., et al. 2002. Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature. 415:339-343.
39. Stambolic, L., Ruel, V., and Woodgett, J.R. 1996. Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells. Curr. Biol. 6:1664-1668.
40. Cross, D.A., et al. 2001. Selective small-molecule inhibitors of glycogen synthase kinase-3 activity protect primary neurones from death. J. Neurochem. 77:94-102.
41. Bijur, G.N., and Jope, R.S. 2003. Rapid accumulation of Akt in mitochondria following phosphatidylinositol 3-kinase activation. J. Neurochem. 87:1427-1435.
42. Dajani, R., et al. 2001. Crystal structure of glycogen synthase kinase 3 beta: structural basis for phosphate-primed substrate specificity and autoinhibition. Cell. 105:721-732.
43. Cave, A.C., Collis, C.S., Downey, J.M., and Hearse, D.J. 1993. Improved functional recovery by ischaemic preconditioning is not mediated by adenosine in the globally ischaemic isolated rat heart. Cardiovasc. Res. 27:663-668.
44. Ganote, C.E., Armstrong, S., and Downey, J.M. 1993. Adenosine and A1 selective agonists offer minimal protection against ischaemic injury to isolated rat cardiomyocytes. Cardiovasc. Res. 27:1670-1676.
45. Armstrong, S., Downey, J.M., and Ganote, C.E. 1994. Preconditioning of isolated rabbit cardiomyocytes: induction by metabolic stress and blockade by the adenosine antagonist SPT and calphostin C, a protein kinase C inhibitor. Cardiovasc. Res. 28:72-77.
46. Sato, T., O'Rourke, B., and Marban, E. 1998. Modulation of mitochondrial ATP-dependent K+ channels by protein kinase C. Circ. Res. 83:110-114.
47. Mochly-Rosen, D. 1995. Localization of protein kinases by anchoring proteins: a theme in signal transduction. Science. 268:247-251.
48. Yaffe, M.B., et al. 2001. A motif-based profile scanning approach for genome-wide prediction of signaling pathways. Nat. Biotechnol. 19:348-353.
49. Boeckmann, B., et al. 2003. The SWISS-PROT protein knowledgebase and its supplement TrEMBL in 2003. Nucleic Acids Res. 31:365-370.
50. Lee, J.H., et al. 1999. Bis, a Bcl-2-binding protein that synergizes with Bcl-2 in preventing cell death. Oncogene. 18:6183-6190.
51. Ojala, P.M., et al. 2000. The apoptotic v-cyclin-CDK6 complex phosphorylates and inactivates Bcl-2. Nat. Cell Biol. 2:819-825.
52. Haldar, S., Jena, N., and Croce, C.M. 1995. Inactivation of Bcl-2 by phosphorylation. Proc. Natl. Acad. Sci. U. S. A. 92:4507-4511.
53. Chen, Z., Chua, C.C., Ho, Y.S., Hamdy, R.C., and Chua, B.H. 2001. Overexpression of Bcl-2 attenuates apoptosis and protects against myocardial 1/R injury in transgenic mice. Am. J. Physiol. 280:H2313-H2320.
54. Brocheriou, V., et al. 2000. Cardiac function improvement by a human Bcl-2 transgene in a mouse model of ischemia/reperfusion injury. J. Gene Med. 2:326-333.
55. Shimizu, S., Konishi, A., Kodama, T., and Tsujimoto, Y. 2000. BH4 domain of antiapoptotic Bcl-2 family members closes voltage-dependent anion channel and inhibits apoptotic mitochondrial changes and cell death. Proc. Natl. Acad. Sci. U. S. A. 97:3100-3105.
56. Chen, M., Won, D.J., Krajewski, S., and Gottlieb, R.A. 2002. Calpain and mitochondria in ischemia/ reperfusion injury. J. Biol. Chem. 277:29181-29186.
57. Garratt, K.N., et al. 1999. Sulfonylurea drugs increase early mortality in patients with diabetes mellitus after direct angioplasty for acute myocardial infarction. J. Am. Coll. Cardiol. 33:119-124.
58. Scognamiglio, R., et al. 2002. Effects of treatment with sulfonylurea drugs or insulin on ischemia-induced myocardial dysfunction in type 2 diabetes. Diabetes. 51:808-812.
59. Heart Protection Study Collaborative Group. 2002. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 360:23-33.
60. Stanley, W.C. 2002. Partial fatty acid oxidation inhibitors for stable angina. Expert Opin. Investig. Drugs. 11:615-629.
61. Abete, P., et al. 1996. Preconditioning does not prevent postischemic dysfunction in aging heart. J. Am. Coll. Cardiol. 27:1777-1786.
62. Wallace, D.C., and Melov, S. 1998. Radicals r'aging. Nat. Genet. 19:105-106.